Surgery Partners (NASDAQ:SGRY) Upgraded at ValuEngine

ValuEngine upgraded shares of Surgery Partners (NASDAQ:SGRY) from a sell rating to a hold rating in a report issued on Thursday morning, ValuEngine reports.

A number of other brokerages have also weighed in on SGRY. BidaskClub raised Surgery Partners from a strong sell rating to a sell rating in a report on Saturday, July 27th. Stifel Nicolaus set a $12.00 price objective on Surgery Partners and gave the company a hold rating in a report on Wednesday, May 8th. Finally, Zacks Investment Research lowered Surgery Partners from a hold rating to a sell rating in a report on Wednesday, May 15th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the stock. Surgery Partners currently has an average rating of Hold and an average price target of $17.60.

Shares of NASDAQ SGRY traded down $0.50 during midday trading on Thursday, reaching $6.96. 358,611 shares of the company were exchanged, compared to its average volume of 331,637. The company has a current ratio of 1.49, a quick ratio of 1.37 and a debt-to-equity ratio of 2.20. Surgery Partners has a 1 year low of $6.41 and a 1 year high of $18.70. The company’s fifty day moving average is $7.86. The company has a market capitalization of $368.73 million, a PE ratio of -2.84 and a beta of 2.27.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Wednesday, May 8th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.39) by ($0.03). Surgery Partners had a negative return on equity of 4.01% and a negative net margin of 11.59%. The company had revenue of $416.80 million for the quarter, compared to analysts’ expectations of $421.41 million. During the same period in the prior year, the business earned ($0.26) EPS. The business’s quarterly revenue was up 1.3% compared to the same quarter last year. As a group, equities research analysts predict that Surgery Partners will post -0.65 earnings per share for the current year.

In other Surgery Partners news, Director Adam T. Feinstein sold 7,865 shares of Surgery Partners stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $9.95, for a total value of $78,256.75. Following the sale, the director now owns 8,895 shares of the company’s stock, valued at approximately $88,505.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 2.30% of the stock is currently owned by insiders.

Hedge funds have recently bought and sold shares of the company. Millennium Management LLC acquired a new stake in shares of Surgery Partners during the 4th quarter valued at approximately $1,595,000. Barclays PLC lifted its position in shares of Surgery Partners by 84.7% during the 4th quarter. Barclays PLC now owns 23,145 shares of the company’s stock valued at $226,000 after acquiring an additional 10,615 shares during the period. BlackRock Inc. lifted its position in shares of Surgery Partners by 16.9% during the 4th quarter. BlackRock Inc. now owns 1,452,957 shares of the company’s stock valued at $14,225,000 after acquiring an additional 209,539 shares during the period. Clearbridge Investments LLC lifted its position in shares of Surgery Partners by 3.9% during the 1st quarter. Clearbridge Investments LLC now owns 3,667,811 shares of the company’s stock valued at $41,373,000 after acquiring an additional 138,158 shares during the period. Finally, Elk Creek Partners LLC lifted its position in shares of Surgery Partners by 5.3% during the 1st quarter. Elk Creek Partners LLC now owns 1,373,263 shares of the company’s stock valued at $15,490,000 after acquiring an additional 69,669 shares during the period. Institutional investors own 90.03% of the company’s stock.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Further Reading: Swap

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.